Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Oruka Therapeutics - 27 Year Stock Price History | ORKA

Historical daily share price chart and data for Oruka Therapeutics since 1997 adjusted for splits and dividends. The latest closing stock price for Oruka Therapeutics as of September 17, 2024 is 26.47.
  • The all-time high Oruka Therapeutics stock closing price was 41803322.28 on February 18, 2000.
  • The Oruka Therapeutics 52-week high stock price is 53.90, which is 103.6% above the current share price.
  • The Oruka Therapeutics 52-week low stock price is 18.73, which is 29.2% below the current share price.
  • The average Oruka Therapeutics stock price for the last 52 weeks is 29.40.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Oruka Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 20.2350 12.2392 30.3428 11.5230 26.4700 113.47%
2023 14.8732 17.6513 18.5996 12.3632 12.3997 -28.27%
2022 16.2512 16.7761 18.4537 12.9103 17.2867 10.23%
2021 24.4176 30.3428 38.6579 15.6820 15.6820 -46.38%
2020 36.4738 41.4296 140.1167 16.9220 29.2487 -29.78%
2019 47.9482 43.3260 110.1386 36.1050 41.6535 -4.87%
2018 96.4504 177.2429 249.4529 36.7615 43.7856 -75.30%
2017 261.7010 355.7987 374.1794 137.8556 177.2429 -52.63%
2016 414.2921 609.1903 627.5711 282.2757 374.1794 -38.71%
2015 781.8426 955.7986 1387.7460 605.0940 610.5033 -30.34%
2014 1338.2544 1589.9342 2077.1158 652.5164 876.3938 -43.24%
2013 1774.5389 2260.8313 4758.7742 1102.8445 1543.9824 -26.32%
2012 3149.0491 5514.2227 5734.7916 1268.2712 2095.4046 -62.00%
2011 10308.0800 17369.8015 18141.7927 5456.3234 5514.2227 -68.45%
2010 20427.3857 18086.6505 45327.7929 14557.5479 17480.0860 -2.76%
2009 25575.8640 35291.0253 74166.2953 12407.0011 17976.3660 -47.42%
2008 82198.9703 196306.3281 204026.2398 27571.1135 34188.1807 -83.06%
2007 307781.5026 417978.0805 626415.6985 141164.1011 201820.5508 -54.25%
2006 1820717.2466 940726.3924 2282888.1972 430109.3705 441137.8159 -50.68%
2005 893566.6592 1086301.8716 1139238.4095 642958.3666 894406.9217 -17.66%
2004 1161374.0749 1191072.1029 1806459.3560 816104.9594 1086301.8716 -6.19%
2003 671225.3225 274608.2904 1356498.7838 234905.8870 1157986.7667 302.30%
2002 1047452.8598 2689837.8323 2865190.1141 287842.4249 287842.4249 -88.75%
2001 3449146.2979 4843693.2183 5713837.5602 1819693.4905 2557496.4875 -46.28%
2000 12530138.9161 5174546.5802 41803322.2771 4013251.2799 4760979.8779 -15.40%
1999 1563899.2028 1654266.8095 6001679.9850 860218.7410 5627815.6861 224.00%
1998 2925334.5288 3146415.4717 4926406.5588 1406126.7881 1736980.1500 -45.48%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.031B $0.000B
Oruka Therapeutics Inc. is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka Therapeutics Inc., formerly known as ARCA biopharma Inc., is based in WESTMINSTER, Colo.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $88.005B 35.06
Takeda Pharmaceutical (TAK) Japan $47.092B 9.43
Merck (MKGAF) Germany $24.640B 26.89
Astellas Pharma (ALPMY) Japan $21.861B 26.26
Summit Therapeutics (SMMT) United States $21.359B 0.00
Sandoz Group AG (SDZNY) Switzerland $17.662B 0.00
United Therapeutics (UTHR) United States $15.349B 15.85
Shionogi (SGIOY) Japan $13.202B 12.65
Neurocrine Biosciences (NBIX) United States $12.344B 36.93
Catalent (CTLT) United States $10.917B 0.00
Revolution Medicines (RVMD) United States $7.440B 0.00
Orion OYJ (ORINY) Finland $7.373B 30.02
Jazz Pharmaceuticals (JAZZ) Ireland $6.766B 7.18
Ionis Pharmaceuticals (IONS) United States $5.951B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.660B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.068B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.317B 0.00
Corcept Therapeutics (CORT) United States $4.020B 34.04
Dyne Therapeutics (DYN) United States $3.454B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.718B 15.68
PTC Therapeutics (PTCT) United States $2.598B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.542B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.426B 19.28
Soleno Therapeutics (SLNO) United States $2.052B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.869B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.865B 0.00
Xencor (XNCR) United States $1.649B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.636B 0.00
Harrow (HROW) United States $1.560B 0.00
Ardelyx (ARDX) United States $1.464B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.426B 0.00
Ocular Therapeutix (OCUL) United States $1.392B 0.00
Cassava Sciences (SAVA) United States $1.360B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.330B 0.00
Indivior (INDV) United States $1.315B 6.04
ARS Pharmaceuticals (SPRY) United States $1.255B 0.00
Evotec AG (EVO) Germany $1.240B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.221B 0.00
Collegium Pharmaceutical (COLL) United States $1.195B 6.86
Relay Therapeutics (RLAY) United States $1.086B 0.00
Enliven Therapeutics (ELVN) United States $1.057B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.020B 0.00
Bioventus (BVS) United States $0.896B 29.10
4D Molecular Therapeutics (FDMT) United States $0.856B 0.00
Cronos Group (CRON) Canada $0.856B 0.00
USANA Health Sciences (USNA) United States $0.730B 13.40
Ironwood Pharmaceuticals (IRWD) United States $0.714B 44.70
Savara (SVRA) United States $0.711B 0.00
ProKidney (PROK) United States $0.678B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.649B 0.00
Pacira BioSciences (PCRX) United States $0.622B 5.89
Exscientia (EXAI) United Kingdom $0.612B 0.00
Siga Technologies (SIGA) United States $0.570B 6.83
Eliem Therapeutics (ELYM) United States $0.553B 0.00
Silence Therapeutics (SLN) United Kingdom $0.546B 0.00
OmniAb (OABI) United States $0.539B 0.00
Altimmune (ALT) United States $0.539B 0.00
Tourmaline Bio (TRML) United States $0.516B 0.00
Foghorn Therapeutics (FHTX) United States $0.512B 0.00
KalVista Pharmaceuticals (KALV) United States $0.465B 0.00
Sage Therapeutics (SAGE) United States $0.462B 0.00
Verve Therapeutics (VERV) United States $0.459B 0.00
Aquestive Therapeutics (AQST) United States $0.452B 0.00
Xeris Biopharma Holdings (XERS) United States $0.429B 0.00
Larimar Therapeutics (LRMR) United States $0.427B 0.00
Elite Pharmaceuticals (ELTP) United States $0.416B 38.98
Zevra Therapeutics (ZVRA) United States $0.409B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.397B 0.00
Korro Bio (KRRO) United States $0.380B 0.00
Organogenesis (ORGO) United States $0.379B 0.00
Aldeyra Therapeutics (ALDX) United States $0.351B 0.00
Esperion Therapeutics (ESPR) United States $0.345B 0.00
Lyell Immunopharma (LYEL) United States $0.317B 0.00
Lexeo Therapeutics (LXEO) United States $0.317B 0.00
ESSA Pharma (EPIX) Canada $0.311B 0.00
Black Diamond Therapeutics (BDTX) United States $0.306B 0.00
Akebia Therapeutics (AKBA) United States $0.294B 0.00
Heron Therapeutics (HRTX) United States $0.278B 0.00
Avita Medical (RCEL) United States $0.267B 0.00
Nature's Sunshine Products (NATR) United States $0.256B 17.48
Acrivon Therapeutics (ACRV) United States $0.255B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.250B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.242B 0.00
Nektar Therapeutics (NKTR) United States $0.234B 0.00
Nanobiotix S.A (NBTX) France $0.232B 0.00
Pyxis Oncology (PYXS) United States $0.213B 0.00
MediWound (MDWD) Israel $0.195B 0.00
Profound Medical (PROF) Canada $0.190B 0.00
CytoDyn (CYDY) United States $0.189B 0.00
Innate Pharma SA (IPHYF) France $0.184B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.180B 0.00
Telomir Pharmaceuticals (TELO) United States $0.177B 0.00
Galectin Therapeutics (GALT) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.167B 0.00
Cardiol Therapeutics (CRDL) Canada $0.159B 0.00
Context Therapeutics (CNTX) United States $0.156B 0.00
Achieve Life Sciences (ACHV) Canada $0.152B 0.00
Prelude Therapeutics (PRLD) United States $0.143B 0.00
Century Therapeutics (IPSC) United States $0.135B 0.00
OptiNose (OPTN) United States $0.134B 0.00
Fractyl Health (GUTS) United States $0.127B 0.00
Assertio Holdings (ASRT) United States $0.118B 20.67
Journey Medical (DERM) United States $0.113B 0.00
Incannex Healthcare (IXHL) Australia $0.110B 0.00
CASI Pharmaceuticals (CASI) China $0.107B 0.00
Regulus Therapeutics (RGLS) United States $0.103B 0.00
Metagenomi (MGX) United States $0.103B 0.00
Karyopharm Therapeutics (KPTI) United States $0.095B 0.00
Relmada Therapeutics (RLMD) United States $0.091B 0.00
Citius Pharmaceuticals (CTXR) United States $0.091B 0.00
AlloVir (ALVR) United States $0.088B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.085B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.081B 0.00
PMV Pharmaceuticals (PMVP) United States $0.077B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.33
Arch Biopartners (ACHFF) Canada $0.071B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
Mural Oncology (MURA) Ireland $0.055B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Nutriband (NTRB) United States $0.050B 0.00
DURECT (DRRX) United States $0.048B 0.00
Inotiv (NOTV) United States $0.048B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.046B 0.00
ProPhase Labs (PRPH) United States $0.046B 0.00
FibroGen (FGEN) United States $0.045B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Protara Therapeutics (TARA) United States $0.039B 0.00
Gain Therapeutics (GANX) United States $0.038B 0.00
Unicycive Therapeutics (UNCY) United States $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Tempest Therapeutics (TPST) United States $0.034B 0.00
Enlivex Therapeutics (ENLV) Israel $0.033B 0.00
Surrozen (SRZN) United States $0.028B 0.00
VYNE Therapeutics (VYNE) United States $0.028B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.026B 0.00
Lipocine (LPCN) United States $0.025B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
Minerva Neurosciences (NERV) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.020B 0.78
TherapeuticsMD (TXMD) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
NRx Pharmaceuticals (NRXP) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Indaptus Therapeutics (INDP) United States $0.016B 0.00
Talphera (TLPH) United States $0.015B 0.00
Aptorum Group (APM) United Kingdom $0.015B 0.00
Nuvilex (PMCB) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Conduit Pharmaceuticals (CDT) United States $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
GlycoMimetics (GLYC) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Vivos Therapeutics (VVOS) United States $0.010B 0.00
Viracta Therapeutics (VIRX) United States $0.009B 0.00
Avalo Therapeutics (AVTX) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.52
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.69